The Harm Reduction Consortium brings together seven of the leading international and regional harm reduction, drug policy and drug user networks: IDPC, Harm Reduction International (HRI), Youth RISE, the Middle East and North Africa Harm Reduction Association (MENAHRA), the Eurasian Harm Reduction Network (EHRN), the European Network of People who Use Drugs (EuroNPUD), and the Eurasian Network of People who Use Drugs (ENPUD).
The Consortium works together to deliver a long-term programme to strengthen civil society advocacy for the “critical enablers” of the HIV response for people who use drugs. The Consortium approach dates back to advocacy funding from the UK Department for International Development between 2006 and 2012, and has since been supported by core funding from the Robert Carr civil society Networks Fund (RCNF).
Together, the Consortium partners have a proven track record of effective collaboration on joint projects, advocacy and events. The current three-year grant from RCNF focuses on four critical factors facing this population: inadequate harm reduction funding and coverage; harmful social and legal environments; widespread human rights violations; and insufficient civil society capacity. The overarching mission of the Harm Reduction Consortium is to end HIV transmission among people who inject drugs – in line with the RCNF vision of zero new HIV infections, zero discrimination, and zero AIDS-related deaths.